您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    我国内窥镜产业现状及展望(2012~2019)

    摘要

    内窥镜市场规模在2018年达到约200亿元,软管式内窥镜主要由奥林巴斯、富士胶片和宾得三家日企巨头垄断,其市场份额超过95%;以腹腔镜为主的硬管式内窥镜主要由卡尔史托斯、奥林巴斯和史赛克等国外公司垄断,其市场份额超过90%。国产内窥镜主要以较低端内窥镜为主,在产品性能、品牌影响力方面明显落后于国外主流产品。近年来,随着国家政策支持以及资本市场对国产内窥镜领域的关注和投资,国产内窥镜将加快前沿技术开发,提高产品性能和品牌影响力,进口替代是国产内窥镜面临的挑战和机遇。

    <<
    >>

    Abstract

    The endoscopy market reached about 20 billion yuan in 2017. and the digestive electronic soft endoscope was mainly monopolized by three Japanese giants,Olympus,Fuji film and pentax,whose market share exceeded 95%. The hard endoscopes dominated by laparoscopy were mainly monopolized by foreign companies such as Karl Storz,Olympus and Stryker,with a market share of more than 90%. Domestic endoscopes are mainly low-end endoscopes,which obviously lag behind foreign mainstream products in terms of product performance and brand influence. In recent years,with the support of national policy and capital market’s attention and investment in domestic endoscopy field,accelerating the development of frontier technology,improving the performance and brand of domestic endoscopy medical devices,import substitution is the challenge and opportunity of domestic endoscopy.

    <<
    >>
    作者简介
    白晓淞:白晓淞,深圳英美达医疗技术有限公司董事长。
    <<
    >>
    相关报告